Herantis Pharma Plc launches a directed offering of new shares to raise a minimum of EUR 5 million
Herantis Pharma PlcCompany release, inside information, 26 May 2020 at 6:30 p.m. Eastern European Summer Time THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Herantis Pharma Plc ("Herantis" or the "Company") hereby announces its intention to issue new shares (the "Placing Shares") in an offering directed to a selected group of investors (the "Placing")